February 18, 2021 by Chain Drug Review
COVID-19, The Council for Responsible Nutrition (CRN)
Leading Headlines, Supplier News

WASHINGTON — The Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement and functional food industry, applauds U.S. Representative Glenn Grothman (R-WI) for introducing a House Resolution (H. Res. 116) that recognizes the potential role vitamin D may play in decreasing the severity of COVID-19. The resolution calls on the Centers
February 1, 2021 by Brian Bossetta
COVID-19, FEMA, President Joe Biden
February 1, 2021, News

WASHINGTON — During his inaugural address and throughout his campaign, President Joe Biden spoke of the need to unify the nation and how doing so would require all Americans pulling in the same direction. Less than 24 hours after he took office the 46th president’s call had already been embraced by one major group, retail
January 25, 2021 by Chain Drug Review
COVID-19, Emergen-C, Immune Health
Supplier News

WARREN, N.J. — For many Americans, living through 2020 has caused a dramatic shift in priorities, with their health, and the health of their loved ones especially, rising to the top as the most important concern. In fact, a nationally representative survey revealed more Americans care about the health of their loved ones more than they
January 22, 2021 by Chain Drug Review
Chip Davis, COVID-19, HDA, health care distribution industry
Leading Headlines, Pharmacy

ARLINGTON, Va. — HDA president and CEO Chester “Chip” Davis, Jr., released the following statement in response to recent commentary related to the COVID-19 vaccination effort: “HDA and the health care distribution industry are committed to doing whatever is necessary to assist the Biden administration in meeting its goal of administering 100 million vaccines to
January 22, 2021 by Chain Drug Review
COVID-19, Walgreens
Featured Articles, Leading Headlines, Pharmacy, Retail News

DEERFIELD, Ill. — Walgreens reported that it has administered more than 1 million COVID-19 vaccinations across long-term care facilities and other vulnerable populations identified as part of state and jurisdiction distribution plans. The company also remains on track to complete the administration of COVID-19 vaccine first doses in skilled nursing facilities by Monday, Jan. 25.
January 14, 2021 by Chain Drug Review
COVID-19, COVID-19 rapid antibody testing, Hy-Vee Inc.
Leading Headlines, Pharmacy

WEST DES MOINES, Iowa — Hy-Vee, Inc. will begin offering COVID-19 rapid antibody testing at more than 250 Hy-Vee pharmacy locations on Monday, Jan. 18. Patients will receive same day test results in as few as 15 minutes after completing the test. The rapid antibody test is available for patients who wish to learn if they
January 11, 2021 by Chain Drug Review
2021 dunnhumby Retailer Preference Index, COVID-19
Business, Leading Headlines, Retail News

CHICAGO – dunnhumby released today the fourth annual dunnhumby Retailer Preference Index (RPI) a comprehensive, nationwide study that examines the approximately $1 trillion U.S. grocery market. In a year dominated by COVID-19, Amazon eclipsed last year’s winner H-E-B and runner up Trader Joe’s to take the top spot. For the first time, Target, due to
January 4, 2021 by Chain Drug Review
COVID-19, Fuel Your School campaign, Hy-Vee
Leading Headlines, Retail News

WEST DES MOINES, Iowa – Hy-Vee, Inc. is pledging $75,000 to be awarded among 55 schools across its eight-state region. The pledge is part of the company’s Fuel Your School campaign, which runs now through Jan. 31. Hy-Vee’s Fuel Your School campaign allows customers to enter its sweepstakes by simply purchasing specific brands found at
January 4, 2021 by Chain Drug Review
COVID-19, Creche Innovations, Pandemic Mobile Command Center (PMCC) with built-in MicroCool Refrigeration
Supplier News, Technology

OVERLAND PARK, Kan. — As health care workers and residents of long-term care facilities in the United States start receiving their first dose of the COVID-19 vaccine, Creche Innovations, along with a COVID-19 vaccine focus group comprised of physicians, nurses and pharmacists from across the country, have developed the Pandemic Mobile Command Center (PMCC) with
January 4, 2021 by Jeffrey Woldt
chain drug industry, COVID-19
January 4, 2021, Opinion

When industry observers look back at a given year, all too often they resort to hyperbole, making shaky claims about the long-term significance of events. The year just ended eliminated that pitfall, at least temporarily: 2020 crystallized several issues — the nation’s deep political divide, the quest for racial justice and the need to act
December 22, 2020 by Chain Drug Review
COVID-19, Dr. Reddy’s, Reeqonus
Leading Headlines, Pharmacy

MISSISSAUGA, Ontario — Dr. Reddy’s has filed an application for Reeqonus (favipiravir) tablets for acute treatment of mild to moderate COVID-19 adult patients under Health Canada’s Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Reeqonus is also known as Avigan, which was developed by Fujifilm Toyama Chemical
December 17, 2020 by Chain Drug Review
COVID-19, FDA, Moderna Vaccine
Leading Headlines, Pharmacy

WASHINGTON — A panel of outside advisers to the U.S. Food and Drug Administration on Thursday endorsed emergency use of Moderna’s coronavirus vaccine, virtually assuring a second option for protecting against COVID-19 for a pandemic ravaged nation. Members of the Vaccines and Related Biological Products Advisory Committee voted 20-0 with one abstention in favor of
December 16, 2020 by Chain Drug Review
COVID-19, National Community Pharmacists Association
Leading Headlines, Pharmacy

ALEXANDRIA, Va. — The National Community Pharmacists Association today urged congressional leaders to extend the Paycheck Protection Program and pass several other provisions aimed at helping independent pharmacies on the front line of the fight against COVID-19. “As end-of-year negotiations are underway to finalize a FY21 spending package and COVID-19 relief legislation, we request that you strongly
December 16, 2020 by Chain Drug Review
COVID-19, SingleCare
Business, Leading Headlines, Pharmacy

BOSTON — SingleCare (prescription savings service) just released a new report that explores major shifts in 2020 prescription drug trends due to COVID. This year was a watershed moment for healthcare’s national impact to access to medications. From the start of the outbreak in the U.S. in March 2020, millions across the country experienced drug